Rise Advisors, LLC Nektar Therapeutics Transaction History
Rise Advisors, LLC
- $249 Million
- Q3 2025
A detailed history of Rise Advisors, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Rise Advisors, LLC holds 69 shares of NKTR stock, worth $3,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 49
40.82%
Holding current value
$3,910
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NKTR
# of Institutions
19Shares Held
15.6MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY15.2MShares$859 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$18.5 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$2.92 Million0.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO12KShares$680,1600.0% of portfolio
-
Ropes Wealth Advisors LLC Boston, MA11.6KShares$656,3540.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $10.6B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...